The authors' reply to Schaffzin et al's Letter to the Editor

被引:0
|
作者
Biebelberg, Brett [1 ,2 ]
Klompas, Michael [3 ,4 ,5 ]
Rhee, Chanu [3 ,4 ,5 ]
机构
[1] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
[2] Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[3] Harvard Med Sch, Dept Populat Med, Boston, MA USA
[4] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA USA
关键词
D O I
10.1017/ice.2023.222
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:2098 / 2098
页数:1
相关论文
共 50 条
  • [21] Reply by the authors to the letter by Aksoy et al.
    Ath. Kehagias
    V. Petridis
    E. Nidelkou
    Stochastic Environmental Research and Risk Assessment, 2007, 21 (4) : 451 - 455
  • [22] Authors’ reply to letter of Vandijck et al.
    R. Raz
    Y. Ben-Israel
    D. Gronich
    E. Granot
    R. Colodner
    I. Visotzky
    European Journal of Clinical Microbiology and Infectious Diseases, 2006, 25 (4): : 280 - 280
  • [23] With regard to the letter by Corcoran et al - Authors' reply
    Chetboul, Valerie
    Lefebvre, Herve P.
    Sampedrano, Carolina Carlos
    Gouni, Vassiliki
    Saponaro, Vittorio
    Serres, Francois
    Concordet, Didier
    Nicolle, Audrey P.
    Pouchelon, Jean-Louis
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (02) : 245 - 246
  • [24] Reply to the Editor's Letter by Nedelmann M et al.
    Hansen, Hans-Christian
    Helmke, Knut
    KLINISCHE NEUROPHYSIOLOGIE, 2021, 52 (02) : 106 - 107
  • [25] Authors' response to the letter to the editor by Jowsey et al.
    Sanvido, Olivier
    Schmid, Kaspar
    FitzGerald, Rex E.
    Roth, Nicolas
    Wilks, Martin F.
    Bormann, Peter
    Hopf, Nancy B.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, 103 : 330 - 331
  • [26] Reply Reply to letter to the editor by Xie Kai et al Reply
    Hiranaka, Takafumi
    Mutaguchi, Yukiko
    Yoshikawa, Ryo
    Nakanishi, Yuta
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2022, 27 (04) : 961 - 962
  • [27] Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation"
    Durrani, Khayyam
    Kempen, John H.
    Foster, C. Stephen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (01) : 71 - 71
  • [28] Letter to the Editor:: Authors' reply
    Gözdasoglu, S
    Ertem, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 34 (01): : 77 - 77
  • [29] Letter to the editor - The authors reply
    Li, YH
    Wang, WJ
    JOURNAL OF DENTAL RESEARCH, 2002, 81 (12) : 805 - 806
  • [30] Authors' Reply to Letter to the Editor
    Meyr, Andrew J.
    JOURNAL OF FOOT & ANKLE SURGERY, 2024, 63 (03): : 431 - 431